搜索
Firefly Neuroscience Inc
AIFF添加自选
1.700USD
-0.080-4.49%
收盘 05/15, 16:00（美东）报价延迟15分钟
26.47M总市值
亏损市盈率 TTM
查看详细走势图
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-4.49%
5天
-10.05%
1月
+3.03%
6月
+15.65%
今年开始到现在
+94.29%
1年
-51.15%
TradingKey Firefly Neuroscience Inc股票评分
单位: USD 更新时间: 2026-05-15操作建议
Firefly Neuroscience Inc当前公司基本面数据相对非常健康，最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理，在软件与IT服务行业排名235/468位。机构持股占比非常高，中期看，股价处于上升通道。近一个月，市场表现较差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Firefly Neuroscience Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
Firefly Neuroscience Inc亮点
亮点风险
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
业绩增长期
公司处于发展阶段，最新年度总收入1.14M美元
利润高增长
公司净利润处于行业前列，最新年度总收入1.14M美元
估值低估
公司最新PE估值-4.74，处于3年历史低位
机构减仓
最新机构持股1.05M股，环比减少41.27%
先锋集团持仓
明星投资者先锋集团持仓，最新持仓市值0.00
活跃度降低
近期活跃度降低，过去20天平均换手率-0.80
分析师目标
根据
0
位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Firefly Neuroscience Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Firefly Neuroscience Inc简介
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
公司代码AIFF
公司Firefly Neuroscience Inc
CEOLipschitz (Greg)
网址https://fireflyneuro.com/
相关品种
